Latest news
Novo Nordisk's Failed Heart Drug Trial Sets Up a High-Stakes Reckoning With Investors - AD HOC NEWSAD HOC NEWS · Mon, 03 Aug 2026 03:42:02 GMTNovo Nordisk Shares Slide as Experimental Heart Drug Ziltivekimab Misses Key Trial Goal - Annual Financial Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 12:29:16 GMTNVO Stock Ends Three-Month Winning Streak As Novo Nordisk’s Key Heart Drug Flops, Competition Goes To Court - StocktwitsStocktwits · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk shares tumble after heart drug misses key late-stage trial endpoint - CNBC TV18CNBC TV18 · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk Shares Plunge as Heart Drug Ziltivekimab Fails Key Clinical Trial - Diluted EPS Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 07:00:00 GMT